Vaping habits and respiratory symptoms using a smartphone app platform.
App platforms
E-cigarettes
Electronic nicotine delivery devices
Epidemiology
Repeated measures
Respiratory health
Vaping
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
30 Jul 2024
30 Jul 2024
Historique:
received:
08
10
2023
accepted:
10
07
2024
medline:
31
7
2024
pubmed:
31
7
2024
entrez:
30
7
2024
Statut:
epublish
Résumé
Widespread use of e-cigarette (EC) or vaping products causes respiratory disorders including the nationwide outbreak of e-cigarette or vaping product use-associated lung injury (EVALI) in 2019. Chronic adverse health effects are now being reported as well. To address this important public health issue, an innovative approach of epidemic control and epidemiologic study is required. We aimed to assess the association between short-term and long-term use of EC products and respiratory health in adults using smartphone app data. A population-based, repeated measures, longitudinal smartphone app study that performed 8-day survey participation over 60 days for each participant from August 2020 to March 2021, including 306 participants aged 21 years and older in the US. The participants were asked to complete the respiratory health questionnaire daily, weekly, and monthly on their smartphone app. We analyzed the association between vaping habits and respiratory health using generalized linear mixed models (GLMMs). EC use in the previous 7 days was associated with frequent cough (OR: 5.15, 95% CI: 2.18, 12.21), chronic cough (OR: 3.92, 95% CI: 1.62, 9.45), frequent phlegm (OR: 3.99, 95% CI: 1.44, 11.10), chronic phlegm (OR: 3.55, 95% CI: 1.41, 8.96), episodes of cough and phlegm (OR: 4.68, 95% CI: 1.94, 11.28), mMRC grade 3-4 dyspnea (OR: 3.32, 95% CI: 1.35 to 8.13), chest cold (OR: 3.07, 95% CI: 1.29, 7.33), eye irritation (OR: 2.94, 95% CI: 1.34, 6.47) and nose irritation (OR : 2.02, 95% CI: 0.95, 4.30). Relatively long-term effects of the past 90 days EC use was associated with an increased risk of wheeze (OR: 3.04, 95% CI: 1.31, 7.03), wheeze attack (OR: 2.78, 95% CI: 1.07, 7.24), mMRC grade 3-4 dyspnea (OR: 2.54, 9% CI: 1.05 to 6.18), eye irritation (OR: 3.16, 95% CI: 1.49, 6.68), and eye irritation during the past month (OR: 3.50, 95% CI: 1.52, 8.04). In this smartphone app-based repeated measures study, short-term and relatively long-term use of EC increased the risk of respiratory symptoms.
Sections du résumé
BACKGROUND
BACKGROUND
Widespread use of e-cigarette (EC) or vaping products causes respiratory disorders including the nationwide outbreak of e-cigarette or vaping product use-associated lung injury (EVALI) in 2019. Chronic adverse health effects are now being reported as well. To address this important public health issue, an innovative approach of epidemic control and epidemiologic study is required. We aimed to assess the association between short-term and long-term use of EC products and respiratory health in adults using smartphone app data.
METHODS
METHODS
A population-based, repeated measures, longitudinal smartphone app study that performed 8-day survey participation over 60 days for each participant from August 2020 to March 2021, including 306 participants aged 21 years and older in the US. The participants were asked to complete the respiratory health questionnaire daily, weekly, and monthly on their smartphone app. We analyzed the association between vaping habits and respiratory health using generalized linear mixed models (GLMMs).
RESULTS
RESULTS
EC use in the previous 7 days was associated with frequent cough (OR: 5.15, 95% CI: 2.18, 12.21), chronic cough (OR: 3.92, 95% CI: 1.62, 9.45), frequent phlegm (OR: 3.99, 95% CI: 1.44, 11.10), chronic phlegm (OR: 3.55, 95% CI: 1.41, 8.96), episodes of cough and phlegm (OR: 4.68, 95% CI: 1.94, 11.28), mMRC grade 3-4 dyspnea (OR: 3.32, 95% CI: 1.35 to 8.13), chest cold (OR: 3.07, 95% CI: 1.29, 7.33), eye irritation (OR: 2.94, 95% CI: 1.34, 6.47) and nose irritation (OR : 2.02, 95% CI: 0.95, 4.30). Relatively long-term effects of the past 90 days EC use was associated with an increased risk of wheeze (OR: 3.04, 95% CI: 1.31, 7.03), wheeze attack (OR: 2.78, 95% CI: 1.07, 7.24), mMRC grade 3-4 dyspnea (OR: 2.54, 9% CI: 1.05 to 6.18), eye irritation (OR: 3.16, 95% CI: 1.49, 6.68), and eye irritation during the past month (OR: 3.50, 95% CI: 1.52, 8.04).
CONCLUSIONS
CONCLUSIONS
In this smartphone app-based repeated measures study, short-term and relatively long-term use of EC increased the risk of respiratory symptoms.
Identifiants
pubmed: 39080563
doi: 10.1186/s12889-024-19439-0
pii: 10.1186/s12889-024-19439-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2047Subventions
Organisme : NIOSH CDC HHS
ID : T42 OH008416
Pays : United States
Organisme : NIOSH CDC HHS
ID : T42 OH008416
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Fan K, Zhao Y. Mobile health technology: a novel tool in chronic disease management. Intell Med. 2022;2:41–7.
doi: 10.1016/j.imed.2021.06.003
Moses JC, Adibi S, Shariful Islam SM, Wickramasinghe N, Nguyen L. Application of Smartphone Technologies in Disease Monitoring: a systematic review. Healthc (Basel) 2021; 9(7).
Drew DA, Nguyen LH, Steves CJ, et al. Rapid implementation of mobile technology for real-time epidemiology of COVID-19. Science. 2020;368(6497):1362–7.
doi: 10.1126/science.abc0473
pubmed: 32371477
pmcid: 7200009
Grantz KH, Meredith HR, Cummings DAT, et al. The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology. Nat Commun. 2020;11(1):4961.
doi: 10.1038/s41467-020-18190-5
pubmed: 32999287
pmcid: 7528106
Fore R, Hart JE, Choirat C, et al. Embedding Mobile Health Technology into the nurses’ Health Study 3 to study behavioral risk factors for Cancer. Cancer Epidemiol Biomarkers Prev. 2020;29(4):736–43.
doi: 10.1158/1055-9965.EPI-19-1386
pubmed: 32098894
pmcid: 7171700
Fowles J, Barreau T, Wu N. Cancer and non-cancer risk concerns from metals in Electronic cigarette liquids and aerosols. Int J Environ Res Public Health 2020; 17(6).
Lee MS, Allen JG, Christiani DC. Endotoxin and [Formula: see text] contamination in electronic cigarette products sold in the United States. Environ Health Perspect. 2019;127(4):47008.
doi: 10.1289/EHP3469
Lee MS, LeBouf RF, Son YS, Koutrakis P, Christiani DC. Nicotine, aerosol particles, carbonyls and volatile organic compounds in tobacco- and menthol-flavored e-cigarettes. Environ Health. 2017;16(1):42.
doi: 10.1186/s12940-017-0249-x
pubmed: 28449666
pmcid: 5406907
Allen JG, Flanigan SS, LeBlanc M, et al. Flavoring chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a sample of 51 products, including Fruit-, Candy-, and Cocktail-flavored E-Cigarettes. Environ Health Perspect. 2016;124(6):733–9.
doi: 10.1289/ehp.1510185
pubmed: 26642857
Lee MS, Christiani DC. Microbial Toxins in Nicotine Vaping Liquids. Am J Respir Crit Care Med. 2020;201(6):741–3.
doi: 10.1164/rccm.201911-2178LE
pubmed: 31816248
pmcid: 7068821
Bhatta DN, Glantz SA. Association of E-Cigarette Use with respiratory disease among adults: a longitudinal analysis. Am J Prev Med. 2020;58(2):182–90.
doi: 10.1016/j.amepre.2019.07.028
pubmed: 31859175
Giovanni SP, Keller TL, Bryant AD, Weiss NS, Littman AJ. Electronic cigarette use and chronic respiratory symptoms among U.S. adults. Am J Respir Crit Care Med. 2020;201(9):1157–60.
doi: 10.1164/rccm.201907-1460LE
pubmed: 31922902
pmcid: 7193846
Moshensky A, Du M, Shin J et al. Vaping-induced metabolomic signatures in the circulation of mice are driven by device type, e-liquid, exposure duration and sex. ERJ Open Res 2021; 7(3).
Marrocco A, Singh D, Christiani DC, Demokritou P. E-Cigarette (E-Cig) liquid composition and operational voltage define the in vitro toxicity of Delta8Tetrahydrocannabinol/Vitamin E acetate (Delta8THC/VEA) E-Cig Aerosols. Toxicol Sci. 2022;187(2):279–97.
doi: 10.1093/toxsci/kfac047
pubmed: 35478015
pmcid: 9154258
Harvard AppLab. Vaping and Health Study [Mobile App Version 1.0.2], Google Play. Last Updated Feb 22, 2021. https://play.google.com/store/apps/details?id=com.appslab.vhs .
Harvard AppLab. Vaping and Health Study [Mobile App Version 1.3], Apple Store. Last updated on Mar 22. 2021. https://apps.apple.com/us/app/vaping-and-health-study/id1505514158 .
Shaver LG, Khawer A, Yi Y, et al. Using Facebook Advertising to Recruit Representative Samples: Feasibility Assessment of a cross-sectional survey. J Med Internet Res. 2019;21(8):e14021.
doi: 10.2196/14021
pubmed: 31429409
pmcid: 6718121
Chung KF, McGarvey L, Song WJ, et al. Cough hypersensitivity and chronic cough. Nat Rev Dis Primers. 2022;8(1):45.
doi: 10.1038/s41572-022-00370-w
pubmed: 35773287
pmcid: 9244241
Song WJ, Chang YS, Faruqi S, et al. Defining chronic cough: a systematic review of the Epidemiological Literature. Allergy Asthma Immunol Res. 2016;8(2):146–55.
doi: 10.4168/aair.2016.8.2.146
pubmed: 26739408
Abbasi IN, Ahsan A, Nafees AA. Correlation of respiratory symptoms and spirometric lung patterns in a rural community setting, Sindh, Pakistan: a cross sectional survey. BMC Pulm Med. 2012;12:81.
doi: 10.1186/1471-2466-12-81
pubmed: 23249311
pmcid: 3552941
Mahesh PA, Jayaraj BS, Prabhakar AK, Chaya SK, Vijayasimha R. Prevalence of chronic cough, chronic phlegm & associated factors in Mysore, Karnataka, India. Indian J Med Res. 2011;134:91–100.
pubmed: 21808140
pmcid: 3171924
Hollen PJ, Gralla RJ, Kris MG, Cox C, Belani CP, Grunberg SM, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer. 1994;73:2087–98.
doi: 10.1002/1097-0142(19940415)73:8<2087::AID-CNCR2820730813>3.0.CO;2-X
pubmed: 8156514
Yorke J, Khan N, Garrow A, Tyson S, Singh D, Vestbo J, et al. Evaluation of the individual activity descriptors of the mMRC breathlessness scale: a mixed method study. Int J Chron Obstruct Pulmon Dis. 2022;17:2289–99.
doi: 10.2147/COPD.S372318
pubmed: 36133735
pmcid: 9484771
Bircan E, Bezirhan U, Porter A, Fagan P, Orloff MS. Electronic cigarette use and its association with asthma, chronic obstructive pulmonary disease (COPD) and asthma-COPD overlap syndrome among never cigarette smokers. Tob Induc Dis. 2021;19:75.
doi: 10.18332/tid/142579
pubmed: 34720794
pmcid: 8530195
Tackett AP, Keller-Hamilton B, Smith CE, et al. Evaluation of respiratory symptoms among Youth e-Cigarette users. JAMA Netw Open. 2020;3(10):e2020671.
doi: 10.1001/jamanetworkopen.2020.20671
pubmed: 33048131
pmcid: 8094411
Li D, Sundar IK, McIntosh S, et al. Association of smoking and electronic cigarette use with wheezing and related respiratory symptoms in adults: cross-sectional results from the Population Assessment of Tobacco and Health (PATH) study, wave 2. Tob Control. 2020;29(2):140–7.
pubmed: 30760629
Joshi D, Duong M, Kirkland S, Raina P. Impact of electronic cigarette ever use on lung function in adults aged 45–85: a cross-sectional analysis from the Canadian longitudinal study on aging. BMJ Open. 2021;11(10):e051519.
doi: 10.1136/bmjopen-2021-051519
pubmed: 34706955
pmcid: 8552144
Xie WB, Tackett AP, Berlowitz JB, et al. Association of Electronic cigarette use with respiratory Symptom Development among US Young adults. Am J Resp Crit Care Jun. 2022;1(11):1320–9. https://doi.org/10.1164/rccm.202107-1718OC .
doi: 10.1164/rccm.202107-1718OC
Park JA, Crotty Alexander LE, Christiani DC. Vaping and lung inflammation and Injury. Annu Rev Physiol 2021.
Jonas A. Impact of vaping on respiratory health. BMJ. 2022;378:e065997.
doi: 10.1136/bmj-2021-065997
pubmed: 35851281
Christiani DC. Vaping-Induced Acute Lung Injury. N Engl J Med. 2020;382(10):960–2.
doi: 10.1056/NEJMe1912032
pubmed: 31491071
Tzortzi A, Kapetanstrataki M, Evangelopoulou V, Beghrakis PA, Systematic Literature. Review of e-cigarette-related illness and Injury: not just for the respirologist. Int J Environ Res Public Health 2020; 17(7).
Xie Z, Li D. Cross-sectional Association between Lifetime Use of Electronic cigarettes with or without Marijuana and Self-reported past 12-Month respiratory symptoms as well as Lifetime Respiratory diseases in U.S. adults. Nicotine Tob Res. 2020;22(Suppl 1):S70–5.
doi: 10.1093/ntr/ntaa194
pubmed: 33320251
pmcid: 7737477
Houhamdi L, Fournier PE. Smart apps for self-reporting clinical information. Lancet. 2022;399(10335):1575–6.
doi: 10.1016/S0140-6736(22)00453-6
pubmed: 35397852
pmcid: 8989392
Chan EC, Sun Y, Aitchison KJ, Sivapalan S. Mobile App-based self-report questionnaires for the Assessment and monitoring of bipolar disorder: systematic review. JMIR Form Res. 2021;5(1):e13770.
doi: 10.2196/13770
pubmed: 33416510
pmcid: 7822726